---
title: "CAROL MUALIA — Ownership Dossier"
canonical: https://whiteintel.dev/entity/4bbdd576-a19e-5db9-8325-e9c59e385964
json: https://whiteintel.dev/api/public/dossier/4bbdd576-a19e-5db9-8325-e9c59e385964
identifier: icij:icijol-66003341
jurisdiction: WS
risk: Medium
source: WhiteIntel corporate-ownership graph
---

# CAROL MUALIA

**Type:** Organization  
**Jurisdiction:** WS  
**Identifier:** `icij:icijol-66003341`  
**Risk level:** Medium  
**Canonical dossier:** https://whiteintel.dev/entity/4bbdd576-a19e-5db9-8325-e9c59e385964  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/4bbdd576-a19e-5db9-8325-e9c59e385964  

## Ownership & control

### Holdings / subsidiaries

- **SAMOA PHARMACY LIMITED** (shareholder of) — https://whiteintel.dev/entity/dd649ec6-0655-515f-93dd-89de4a107930

## Provenance

- ICIJ Offshore Leaks — https://offshoreleaks.icij.org/nodes/66003341

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **CAROL MUALIA**. Human view: https://whiteintel.dev/entity/4bbdd576-a19e-5db9-8325-e9c59e385964 · Structured JSON: https://whiteintel.dev/api/public/dossier/4bbdd576-a19e-5db9-8325-e9c59e385964._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._